About | Support Us | Contact
Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.
Home Page > Grant Page

COX-2-dependent modulation of survivin in lung cancer

Institution: University of California, Los Angeles
Investigator(s): Kostyantyn Krysan, Ph.D.
Award Cycle: 2003 (Cycle 12) Grant #: 12FT-0061 Award: $69,500
Subject Area: Cancer
Award Type: Postdoctoral Fellowship Awards
Abstracts
Publications
COX-2-dependent stabilization of survivin in non-small cell lung cancer.
Periodical: FASEB Journal Index Medicus:
Authors: Krysan K, Merchant F, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, et. al ART
Yr: 2004 Vol: 18 Nbr: Abs: Pg: 206-208
COX-2-dependent expression of survivin is critical for apoptosis resistance in NSCLC.
Periodical: Cancer Research Index Medicus:
Authors: Drysan K, Dalwadi H, Sharma S, Pold M, Dubinett SM ART
Yr: 2004 Vol: 64 Nbr: Abs: Pg: 6359 - 6362
Cyclooxygenase-2-Dependent expression of survivin in non-small cell lung cancer.
Periodical: Chest Index Medicus:
Authors: Drysan K, Dohadwalala M, Luo J, Lin Y, Zhu L, et al ART
Yr: 2004 Vol: 125 Nbr: Abs: Pg: 140S
Multifaceted roles of cyclooxygenase-2 in lung cancer.
Periodical: Drug Resistance Updates Index Medicus:
Authors: Riedl K, Drysan K, Pold M, Dalwadi H, et al ART
Yr: 2004 Vol: 7 Nbr: Abs: Pg: 169 - 174
PGE2 activates MAPK/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an EGF receptor-independent manner.
Periodical: Cancer Research Index Medicus:
Authors: Krysan K, Reckamp KL, Dalwadi H, Sharma S, Dohadwala M, Dubinett SM ART
Yr: 2005 Vol: 65 Nbr: Abs: Pg: 6275 - 6281
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.
Periodical: Journal of Leukocyte Biology Index Medicus:
Authors: Baratelli F, Krysan K, Heuze-Vourc'h N, Zhu L, et al ART
Yr: 2005 Vol: 78 Nbr: Abs: Pg: 555 - 564
COX-2 dependent STAT3 activation by IL-6 in non-small cell lung cancer.
Periodical: Clinical Cancer Research Index Medicus:
Authors: Dalwadi H, Drysan K, Heuze-Voure'h N, Pold M, Elashoff D, et al ART
Yr: 0 Vol: Nbr: Abs: Pg:
COX-2-dependent stabilization of survivin in non-small cell lung cancer.
Periodical: FASEB Journal Index Medicus:
Authors: Krysan K, Merchant F, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, et. al ART
Yr: 2004 Vol: 18 Nbr: Abs: Pg: 206-208
COX-2-dependent expression of survivin is critical for apoptosis resistance in NSCLC.
Periodical: Cancer Research Index Medicus:
Authors: Drysan K, Dalwadi H, Sharma S, Pold M, Dubinett SM ART
Yr: 2004 Vol: 64 Nbr: Abs: Pg: 6359 - 6362
Cyclooxygenase-2-Dependent expression of survivin in non-small cell lung cancer.
Periodical: Chest Index Medicus:
Authors: Drysan K, Dohadwalala M, Luo J, Lin Y, Zhu L, et al ART
Yr: 2004 Vol: 125 Nbr: Abs: Pg: 140S
Multifaceted roles of cyclooxygenase-2 in lung cancer.
Periodical: Drug Resistance Updates Index Medicus:
Authors: Riedl K, Drysan K, Pold M, Dalwadi H, et al ART
Yr: 2004 Vol: 7 Nbr: Abs: Pg: 169 - 174
PGE2 activates MAPK/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an EGF receptor-independent manner.
Periodical: Cancer Research Index Medicus:
Authors: Krysan K, Reckamp KL, Dalwadi H, Sharma S, Dohadwala M, Dubinett SM ART
Yr: 2005 Vol: 65 Nbr: Abs: Pg: 6275 - 6281
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.
Periodical: Journal of Leukocyte Biology Index Medicus:
Authors: Baratelli F, Krysan K, Heuze-Vourc'h N, Zhu L, et al ART
Yr: 2005 Vol: 78 Nbr: Abs: Pg: 555 - 564
COX-2 dependent STAT3 activation by IL-6 in non-small cell lung cancer.
Periodical: Clinical Cancer Research Index Medicus:
Authors: Dalwadi H, Drysan K, Heuze-Voure'h N, Pold M, Elashoff D, et al ART
Yr: 0 Vol: Nbr: Abs: Pg: